[1]
Taplin D, Meinking TL. Pyrethrins and pyrethroids in dermatology. Archives of dermatology. 1990 Feb:126(2):213-21
[PubMed PMID: 2405780]
[3]
Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. The Cochrane database of systematic reviews. 2018 Apr 2:4(4):CD012994. doi: 10.1002/14651858.CD012994. Epub 2018 Apr 2
[PubMed PMID: 29608022]
Level 1 (high-level) evidence
[4]
Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J. Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology. 2019 May:80(5):1435-1444. doi: 10.1016/j.jaad.2019.01.004. Epub 2019 Jan 14
[PubMed PMID: 30654070]
Level 1 (high-level) evidence
[5]
Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017 Aug:31(8):1248-1253. doi: 10.1111/jdv.14351. Epub 2017 Jun 22
[PubMed PMID: 28639722]
[6]
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2015 Jun 5:64(RR-03):1-137
[PubMed PMID: 26042815]
[7]
Tiplica GS, Radcliffe K, Evans C, Gomberg M, Nandwani R, Rafila A, Nedelcu L, Salavastru C. 2015 European guidelines for the management of partners of persons with sexually transmitted infections. Journal of the European Academy of Dermatology and Venereology : JEADV. 2015 Jul:29(7):1251-7. doi: 10.1111/jdv.13181. Epub 2015 May 7
[PubMed PMID: 25951082]
[8]
Chosidow O. Clinical practices. Scabies. The New England journal of medicine. 2006 Apr 20:354(16):1718-27
[PubMed PMID: 16625010]
[9]
Devore CD, Schutze GE, Council on School Health and Committee on Infectious Diseases, American Academy of Pediatrics. Head lice. Pediatrics. 2015 May:135(5):e1355-65. doi: 10.1542/peds.2015-0746. Epub
[PubMed PMID: 25917986]
[10]
Vander Stichele RH, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ (Clinical research ed.). 1995 Sep 2:311(7005):604-8
[PubMed PMID: 7545045]
Level 1 (high-level) evidence
[11]
Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012 Sep:31(9):2105-10. doi: 10.1007/s10096-012-1575-0. Epub 2012 Mar 1
[PubMed PMID: 22382818]
[12]
Kalari H, Soltani A, Azizi K, Faramarzi H, Moemenbellah-Fard MD. Comparative efficacy of three pediculicides to treat head lice infestation in primary school girls: a randomised controlled assessor blind trial in rural Iran. BMC dermatology. 2019 Sep 12:19(1):13. doi: 10.1186/s12895-019-0093-5. Epub 2019 Sep 12
[PubMed PMID: 31510998]
Level 2 (mid-level) evidence
[13]
Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC infectious diseases. 2008 Sep 10:8():115. doi: 10.1186/1471-2334-8-115. Epub 2008 Sep 10
[PubMed PMID: 18783606]
Level 2 (mid-level) evidence
[14]
Ko CJ, Elston DM. Pediculosis. Journal of the American Academy of Dermatology. 2004 Jan:50(1):1-12; quiz 13-4
[PubMed PMID: 14699358]
[15]
Tjioe M, Vissers WH. Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation. Drugs & aging. 2008:25(4):299-306
[PubMed PMID: 18361540]
[16]
Tomalik-Scharte D, Lazar A, Meins J, Bastian B, Ihrig M, Wachall B, Jetter A, Tantcheva-Poór I, Mahrle G, Fuhr U. Dermal absorption of permethrin following topical administration. European journal of clinical pharmacology. 2005 Jul:61(5-6):399-404
[PubMed PMID: 15947923]
[17]
Sethi P, Bruckner JV, Mortuza TB, Cummings BS, Muralidhara S, White CA. Plasma Protein and Lipoprotein Binding of Cis- and Trans-Permethrin and Deltamethrin in Adult Humans and Rats. Drug metabolism and disposition: the biological fate of chemicals. 2019 Sep:47(9):941-948. doi: 10.1124/dmd.118.085464. Epub 2019 Jun 27
[PubMed PMID: 31248885]
[18]
Crow JA, Borazjani A, Potter PM, Ross MK. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicology and applied pharmacology. 2007 May 15:221(1):1-12
[PubMed PMID: 17442360]
[19]
Willemin ME, Kadar A, de Sousa G, Leclerc E, Rahmani R, Brochot C. In vitro human metabolism of permethrin isomers alone or as a mixture and the formation of the major metabolites in cryopreserved primary hepatocytes. Toxicology in vitro : an international journal published in association with BIBRA. 2015 Jun:29(4):803-12. doi: 10.1016/j.tiv.2015.03.003. Epub 2015 Mar 9
[PubMed PMID: 25765475]
[20]
Gunning K, Kiraly B, Pippitt K. Lice and Scabies: Treatment Update. American family physician. 2019 May 15:99(10):635-642
[PubMed PMID: 31083883]
[21]
Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics. 2007 May:119(5):965-74
[PubMed PMID: 17473098]
[23]
Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H, Judson FN, Mertz G, Handsfield HH. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Archives of dermatology. 1990 Feb:126(2):167-70
[PubMed PMID: 1689135]
Level 2 (mid-level) evidence
[24]
Burgess IF, Burgess NA, Brunton ER. Tocopheryl acetate 20% spray for elimination of head louse infestation: a randomised controlled trial comparing with 1% permethrin creme rinse. BMC pharmacology & toxicology. 2013 Sep 3:14():43. doi: 10.1186/2050-6511-14-43. Epub 2013 Sep 3
[PubMed PMID: 24004959]
Level 1 (high-level) evidence
[25]
Burgess IF, Brunton ER, Burgess NA. Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC dermatology. 2013 Apr 1:13():5. doi: 10.1186/1471-5945-13-5. Epub 2013 Apr 1
[PubMed PMID: 23548062]
Level 1 (high-level) evidence
[26]
Sunderkötter C, Feldmeier H, Fölster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. S1 guidelines on the diagnosis and treatment of scabies - short version. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016 Nov:14(11):1155-1167. doi: 10.1111/ddg.13130. Epub
[PubMed PMID: 27879074]
[27]
Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy. 2005 Mar:25(3):448-50
[PubMed PMID: 15843294]
[28]
Hill TA, Cohen B. Scabies in babies. Pediatric dermatology. 2017 Nov:34(6):690-694. doi: 10.1111/pde.13255. Epub 2017 Aug 22
[PubMed PMID: 28833468]
[29]
Hoffmann JC, Mößner R, Schön MP, Lippert U. Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2019 Jun:17(6):597-600. doi: 10.1111/ddg.13854. Epub 2019 May 22
[PubMed PMID: 31115965]
[30]
Meinking TL, Taplin D. Safety of permethrin vs lindane for the treatment of scabies. Archives of dermatology. 1996 Aug:132(8):959-62
[PubMed PMID: 8712847]
[31]
Goksugur SB, Karatas Z, Goksugur N, Bekdas M, Demircioglu F. Metabolic acidosis in an infant associated with permethrin toxicity. Pediatric dermatology. 2015 Jan-Feb:32(1):e15-7. doi: 10.1111/pde.12473. Epub 2014 Dec 9
[PubMed PMID: 25487692]
[32]
Drago B, Shah NS, Shah SH. Acute permethrin neurotoxicity: Variable presentations, high index of suspicion. Toxicology reports. 2014:1():1026-1028. doi: 10.1016/j.toxrep.2014.09.007. Epub 2014 Sep 20
[PubMed PMID: 28962315]